| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 259.4 | 180.3 | 197.7 |
| Other income | 5.0 | 2.5 | 4.1 |
| Total income | 264.4 | 182.8 | 201.7 |
| Profit before exceptional items & tax | 61.6 | 33.5 | 31.0 |
| Profit before tax | 61.6 | 33.5 | 31.0 |
| Net profit | 47.5 | 25.6 | 21.0 |
| Operating margin | 23.3% | 18.3% | 15.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +126.20% |
|---|---|
| Net profit, quarter on quarter | +85.50% |
| Revenue, year on year | +31.20% |
Source
Read the filing ↗
BSE results filing, NSE: VENUSREM. Figures extracted from the filing.
Venus Remedies Ltd: key numbers
- Share price
- ₹1,668.40
- Market cap
- ₹2,230 Cr
- Revenue (annual)
- ₹769.6 Cr
- Net profit (annual)
- ₹102.8 Cr
- P/E (TTM)
- 19.2×Sector 50.4×
- Promoter holding
- 41.76%+0.00% QoQ
- FII holding
- 2.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venus Remedies Ltd
All →
17:33 IST
NSE
Other Announcement
Venus Remedies Other Announcement
Venus Remedies Limited has informed the exchanges about its social media posts regarding a special window for the re-lodgement of physical share transfer requests.
18:34 IST
BSE
Financial Results
Venus Remedies Q1 FY27 Results: Net Profit ₹23 Cr, Up 139.6% YoY
Venus Remedies Ltd reported revenue from operations of ₹178.9 Cr (+30.4% YoY) and net profit of ₹23 Cr (+139.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹23 Cr · +139.6% YoY